返回
邵
邵志敏 (Zhi‐Ming Shao)
fudan university shanghai cancer center
46H指数
367论文数
1.3W被引数
收录论文 150
发表时间
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trialfruroliparib 联合或不联合 apatinib 治疗 HER2 阴性转移性乳腺癌携带胚系 BRCA1/2 突变患者(FABULOUS):一项多中心、三臂、开放标签、随机、III 期试验的期中分析

